Skip to main content
OpenTrials

Clinical trial condition

Adult Acute Monoblastic Leukemia (M5a)

Explore clinical trials studying Adult Acute Monoblastic Leukemia (M5a). Study availability and eligibility vary by location and protocol.

40 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adult Acute Monoblastic Leukemia (M5a) trial results

Completed

Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02085408

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 269 locations
View Trial Details
Completed

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

NCT00352365

Conditions
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +31 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Shasta Regional Medical Center Redding, California, United States
  • Sutter Roseville Medical Center Roseville, California, United States
  • Sutter General Hospital Sacramento, California, United States
View all 54 locations
View Trial Details
Completed

Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission

NCT00045435

Conditions
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
Locations
  • OHSU Cancer Institute Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML

NCT00895934

Conditions
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +26 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Harrison HealthPartners Hematology and Oncology-Bremerton Bremerton, Washington, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
  • University of Washington Medical Center Seattle, Washington, United States
View Trial Details

Related conditions